港股异动 | 滔搏(06110.HK)跌4.62% 疫情对公司一季度销售及盈利能力造成负面影响
格隆汇5月3日丨滔搏(06110.HK)跌4.62%,报5.78港元,总市值358亿港元。瑞银发布最新研究报吿,参考同业宝胜国际近期公布的首季盈警,受到疫情影响,公司预计首季收入及纯利同比下跌25%及70%,1月销售同比升13%,但2-3月跌46%及43%。该行预期,疫情也会对滔搏销售及盈利能力造成负面影响。该行提到,与本土体育品牌相比,国际品牌仍面对负面消费情绪及供应链短缺问题。以过往历史来看,去年国际品牌在内地体育市场的市占率已降至58%,折扣率有所提高,显示国际品牌需要更大力度吸引客户。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.